Advertisement

Stereotactic Radiotherapy in the Management of Ventricular Tachycardias

More Questions than Answers?

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Cardiac Electrophysiology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Connolly S.J.
        • Hallstrom A.P.
        • Cappato R.
        • et al.
        Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials.
        Eur Heart J. 2000; 21: 2071-2078
        • Nanthakumar K.
        • Epstein A.E.
        • Kay G.N.
        • et al.
        Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials.
        J Am Coll Cardiol. 2004; 44: 2166-2172
        • Mallidi J.
        • Nadkarni G.N.
        • Berger R.D.
        • et al.
        Meta-analysis of catheter ablation as an adjunct to medical therapy for treatment of ventricular tachycardia in patients with structural heart disease.
        Heart Rhythm. 2011; 8: 503-510
        • Marchlinski F.E.
        • Haffajee C.I.
        • Beshai J.F.
        • et al.
        Long-term success of irrigated radiofrequency catheter ablation of sustained ventricular tachycardia: post-approval THERMOCOOL VT trial.
        J Am Coll Cardiol. 2016; 67: 674-683
        • Sapp J.L.
        • Wells G.A.
        • Parkash R.
        • et al.
        Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs.
        N Engl J Med. 2016; 375: 111-121
        • Aldhoon B.
        • Wichterle D.
        • Peichl P.
        • et al.
        Outcomes of ventricular tachycardia ablation in patients with structural heart disease: the impact of electrical storm.
        PloS One. 2017; 12: e0171830
        • Maskoun W.
        • Saad M.
        • Abualsuod A.
        • et al.
        Outcome of catheter ablation for ventricular tachycardia in patients with ischemic cardiomyopathy: a systematic review and meta-analysis of randomized clinical trials.
        Int J Cardiol. 2018; 267: 107-113
        • Tokuda M.
        • Kojodjojo P.
        • Tung S.
        • et al.
        Acute failure of catheter ablation for ventricular tachycardia due to structural heart disease: causes and significance.
        J Am Heart Assoc. 2013; 2: e000072
        • Loo Jr., B.W.
        • Soltys S.G.
        • Wang L.
        • et al.
        Stereotactic ablative radiotherapy for the treatment of refractory cardiac ventricular arrhythmia.
        Circulation: Arrh Electrophysiol. 2015; 8: 748-750
        • Cvek J.
        • Neuwirth R.
        • Knybel L.
        • et al.
        Cardiac radiosurgery for malignant ventricular tachycardia.
        Cureus. 2014; 6
        • Amino M.
        • Yoshioka K.
        • Tanabe T.
        • et al.
        Heavy ion radiation up-regulates Cx43 and ameliorates arrhythmogenic substrates in hearts after myocardial infarction.
        Cardiovasc Res. 2006; 72: 412-421
        • Amino M.
        • Yoshioka K.
        • Fujibayashi D.
        • et al.
        Year-long upregulation of connexin43 in rabbit hearts by heavy ion irradiation.
        Am J Physiol Heart Circ Physiol. 2010; 298: H1014-H1021
        • Sharma A.
        • Wong D.
        • Weidlich G.
        • et al.
        Noninvasive stereotactic radiosurgery (CyberHeart) for creation of ablation lesions in the atrium.
        Heart Rhythm. 2010; 7: 802-810
        • Gardner E.A.
        • Sumanaweera T.S.
        • Blanck O.
        • et al.
        In Vivo dose measurement using TLDs and MOSFET dosimeters for cardiac radiosurgery.
        J Appl Clin Med Phys. 2012; 13: 3745
        • Blanck O.
        • Bode F.
        • Gebhard M.
        • et al.
        Dose-escalation study for cardiac radiosurgery in a porcine model.
        Int J Radiat Oncol Biol Phys. 2014; 89: 590-598
        • Cuculich P.S.
        • Schill M.R.
        • Kashani R.
        • et al.
        Noninvasive cardiac radiation for ablation of ventricular tachycardia.
        N Engl J Med. 2017; 377: 2325-2336
        • Robinson C.G.
        • Samson P.P.
        • Moore K.M.
        • et al.
        Phase I/II trial of electrophysiology-guided noninvasive cardiac radioablation for ventricular tachycardia.
        Circulation. 2019; 139: 313-321
        • Neuwirth R.
        • Cvek J.
        • Knybel L.
        • et al.
        Stereotactic radiosurgery for ablation of ventricular tachycardia.
        Europace. 2019; 21: 1088-1195
        • Lloyd M.S.
        • Wight J.
        • Schneider F.
        • et al.
        Clinical experience of stereotactic body radiation for refractory ventricular tachycardia in advanced heart failure patients.
        Heart Rhythm. 2020; 17: 415-422
        • Carbucicchio C.
        • Andreini D.
        • Piperno G.
        • et al.
        Stereotactic radioablation for the treatment of ventricular tachycardia: preliminary data and insights from the STRA-MI-VT phase Ib/II study.
        J Interv Card Electrophysiol. 2021; 62: 427-439
        • Ho L.T.
        • Chen J.L.
        • Chan H.M.
        • et al.
        First Asian population study of stereotactic body radiation therapy for ventricular arrhythmias.
        Sci Rep. 2021; 11: 10360
        • Yugo D.
        • Lo L.W.
        • Wu Y.H.
        • et al.
        Case series on stereotactic body radiation therapy in non-ischemic cardiomyopathy patients with recurrent ventricular tachycardia.
        Pacing Clin Electrophysiol. 2021; 44: 1085-1093
        • Gianni C.
        • Rivera D.
        • Burkhardt J.D.
        • et al.
        Stereotactic arrhythmia radioablation for refractory scar-related ventricular tachycardia.
        Heart Rhythm. 2020; 17: 1241-1248
        • Chin R.
        • Hayase J.
        • Hu P.
        • et al.
        Non-invasive stereotactic body radiation therapy for refractory ventricular arrhythmias: an institutional experience.
        J Interv Card Electrophysiol. 2021; 61: 535-543
        • Qian P.C.
        • Quadros K.
        • Aguilar M.
        • et al.
        Substrate modification using stereotactic radioablation to treat refractory ventricular tachycardia in patients with ischemic cardiomyopathy.
        JACC Clin Electrophysiol. 2022; 8: 49-58
        • Blanck O.
        • Buergy D.
        • Vens M.
        • et al.
        Radiosurgery for ventricular tachycardia: preclinical and clinical evidence and study design for a German multi-center multi-platform feasibility trial (RAVENTA).
        Clin Res Cardiol. 2020; 109: 1319-1332
        • Carbucicchio C.
        • Jereczek-Fossa B.A.
        • Andreini D.
        • et al.
        STRA-MI-VT (STereotactic RadioAblation by Multimodal Imaging for Ventricular Tachycardia): rationale and design of an Italian experimental prospective study.
        J Interv Card Electrophysiol. 2021; 61: 583-593
        • Salata C.
        • Ferreira-Machado S.C.
        • De Andrade C.B.V.
        • et al.
        Apoptosis induction of cardiomyocytes and subsequent fibrosis after irradiation and neoadjuvant chemotherapy.
        Int J Radiat Biol. 2014; 90: 284-290
        • Lehmann H.I.
        • Graeff C.
        • Simoniello P.
        • et al.
        Feasibility study on cardiac arrhythmia ablation using high-energy heavy ion beams.
        Scientific Rep. 2016; 6: 38895
        • Kautzner J.
        • Jedlickova K.
        • Sramko M.
        • et al.
        Radiation-induced changes in ventricular myocardium after stereotactic body radiotherapy for recurrent ventricular tachycardia.
        JACC Clin Electrophysiol. 2021; 7: 1487-1492
        • Peichl P.
        • Sramko M.
        • Cvek J.
        • et al.
        A case report of successful elimination of recurrent ventricular tachycardia by repeated stereotactic radiotherapy: the importance of accurate target volume delineation.
        J Eur Heart J Case Rep. 2020; 5: ytaa516
        • Rapp F.
        • Simoniello P.
        • Wiedemann J.
        • et al.
        Biological cardiac tissue effects of high-energy heavy ions e investigation for myocardial ablation.
        Sci Rep. 2019; 9: 5000
        • Kiani S.
        • Kutob L.
        • Schneider F.
        • et al.
        Histopathologic and ultrastructural findings in human myocardium after stereotactic body radiation therapy for recalcitrant ventricular tachycardia.
        Circ Arrhythm Electrophysiol. 2020; 13: e008753
        • Cha M.J.
        • Seo J.W.
        • Kim H.J.
        • et al.
        Early changes in rat heart after high-dose irradiation: implications for antiarrhythmic effects of cardiac radioablation.
        J Am Heart Assoc. 2021; 10: e019072
        • Zhang D.M.
        • Navara R.
        • Yin T.
        • et al.
        Cardiac radiotherapy induces electrical conduction reprogramming in the absence of transmural fibrosis.
        Nat Commun. 2021; 12: 5558
        • Scholz E.P.
        • Seidensaal K.
        • Naumann P.
        • et al.
        Risen from the dead: cardiac stereotactic ablative radiotherapy as last rescue in a patient with refractory ventricular fibrillation storm.
        Heartrhythm Case Rep. 2019; 5: 329-332
        • Jumeau R.
        • Ozsahin M.
        • Schwitter J.
        • et al.
        Rescue procedure for an electrical storm using robotic non-invasive cardiac radio-ablation.
        Radiother Oncol. 2018; 128: 189-191
        • Haskova J.
        • Peichl P.
        • Pirk J.
        • et al.
        Stereotactic radiosurgery as a treatment for recurrent ventricular tachycardia associated with cardiac fibroma.
        HeartRhythm Case Rep. 2018; 5: 44-47
        • Zei P.C.
        • Wong D.
        • Gardner E.
        • et al.
        Safety and efficacy of stereotactic radioablation targeting pulmonary vein tissues in an experimental model.
        Heart Rhythm. 2018; 15: 1420-1427
        • Abdel-Kafi S.
        • Sramko M.
        • Omara S.
        • et al.
        Accuracy of electroanatomical mapping-guided cardiac radiotherapy for ventricular tachycardia: pitfalls and solutions.
        Europace. 2021; 23: 1989-1997
        • Brownstein J.
        • Afzal M.
        • Okabe T.
        • et al.
        Method and atlas to enable targeting for cardiac radioablation employing the American Heart Association segmented model.
        Int J Radiat Oncol Biol Phys. 2021; 111: 178-185
        • Boda-Heggemann J.
        • Blanck O.
        • Mehrhof F.
        • et al.
        Interdisciplinary clinical target volume generation for cardiac radioablation: multicenter benchmarking for the RAdiosurgery for VENtricular TAchycardia (RAVENTA) Trial.
        Int J Radiat Oncol Biol Phys. 2021; 110: 745-756
        • Bear L.R.
        • Huntjens P.R.
        • Walton R.D.
        • et al.
        Cardiac electrical dyssynchrony is accurately detected by noninvasive electrocardiographic imaging.
        Heart Rhythm. 2018; 15: 1058-1069
        • Bhaskaran A.
        • Downar E.
        • Chauhan V.S.
        • et al.
        Electroanatomical mapping-guided stereotactic radiotherapy for right ventricular tachycardia storm. HeartRhythm.
        Case Rep. 2019; 5: 590-592
        • Bradley J.D.
        • Paulus R.
        • Komaki R.
        • et al.
        Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
        Lancet Oncol. 2015; 16: 187-199
        • Wang K.
        • Eblan M.J.
        • Deal A.M.
        • et al.
        Cardiac toxicity after radiotherapy for stage III non-small cell lung cancer: pooled analysis of dose escalation trials delivering 70 to 80 Gy.
        J Clin Oncol. 2017; 35: 1387-1394
        • Banfill K.
        • Giuliani M.
        • Aznar M.
        • et al.
        Cardiac toxicity of thoracic radiotherapy: existing evidence and future directions.
        J Thorac Oncol. 2021; 16: 216-227
        • Gagliardi G.
        • Constine L.S.
        • Moiseenko V.
        • et al.
        Radiation dose-volume effects in the heart.
        Int J Radiat Oncol Biol Phys. 2010; 76: S77-S85
        • Darby S.C.
        • Ewertz M.
        • McGale P.
        • et al.
        Risk of ischemic heart disease in women after radiotherapy for breast cancer.
        N Engl J Med. 2013; 368: 987-998
        • Moiseenko V.
        • Einck J.
        • Murphy J.
        • et al.
        Clinical evaluation of QUANTEC guidelines to predict the risk of cardiac mortality in breast cancer patients.
        Acta Oncol. 2016; 55: 1506-1510
        • Zhang T.W.
        • Snir J.
        • Boldt R.G.
        • et al.
        Is the importance of heart dose overstated in the treatment of non-small cell lung cancer? A systematic review of the literature.
        Int J Radiat Oncol Biol Phys. 2019; 104: 582-589
        • Dess R.T.
        • Sun Y.
        • Matuszak M.M.
        • et al.
        Cardiac events after radiation therapy: combined analysis of prospective multicenter trials for locally advanced non-small-cell lung cancer.
        J Clin Oncol. 2017; 35: 1395-1402
        • Niska J.R.
        • Thorpe C.S.
        • Allen S.M.
        • et al.
        Radiation and the heart: systematic review of dosimetry and cardiac endpoints.
        Expert Rev Cardiovasc Ther. 2018; 16: 931-950
        • Nestle U.
        • De Ruysscher D.
        • Ricardi U.
        • et al.
        ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer.
        Radiother Oncol. 2018; 127: 1-5
        • Corradetti M.N.
        • Haas A.R.
        • Rengan R.
        Central-airway necrosis after stereotactic body-radiation therapy.
        N Engl J Med. 2012; 366: 2327-2329
        • Kong F.S.
        • Moiseenko V.
        • Zhao J.
        • et al.
        Organs at risk considerations for thoracic stereotactic body radiation therapy: what is safe for lung parenchyma?.
        Int J Radiat Oncol Biol Phys. 2021; 110: 172-187
        • Nuyttens J.J.
        • Moiseenko V.
        • McLaughlin M.
        • et al.
        Esophageal dose tolerance in patients treated with stereotactic body radiation therapy.
        Semin Radiat Oncol. 2016; 26: 140-148
        • Mahadevan A.
        • Moningi S.
        • Grimm J.
        • et al.
        Maximizing tumor control and limiting complications with stereotactic body radiation therapy for pancreatic cancer.
        Int J Radiat Oncol Biol Phys. 2021; 110: 206-216
        • Tanaka O.
        • Taniguchi T.
        • Ono K.
        • et al.
        Adrenal stereotactic body radiation therapy: the effects of a full and empty stomach on radiation dose to organs at risk.
        Int J Radiat Oncol Biol Phys. 2021; 111: e481
        • Haskova J.
        • Jedlickova K.
        • Cvek J.
        • et al.
        Oesophagopericardial fistula as a late complication of stereotactic radiotherapy for recurrent ventricular tachycardia.
        Europace. 2022; 9: euab326
        • Robinson C.G.
        • Samson P.
        • Moore K.M.S.
        • et al.
        Longer term results from a Phase I/II study of EP-guided noninvasive cardiac radioablation for treatment of ventricular tachycardia (ENCORE-VT).
        Int J Radiat Oncol. 2019; 105 (abstract): 682
        • Anic A.
        • Breskovic T.
        • Sikiric I.
        • et al.
        Pulsed field ablation: a promise that came true.
        Curr Opin Cardiol. 2021; 36: 5-9
        • McBride S.
        • Avazzadeh S.
        • Wheatley A.M.
        • et al.
        Ablation modalities for therapeutic intervention in arrhythmia-related cardiovascular disease: focus on electroporation.
        J Clin Med. 2021; 10: 2657
        • Reddy V.Y.
        • Anter E.
        • Rackauskas G.
        • et al.
        Lattice-tip focal ablation catheter that toggles between radiofrequency and pulsed field energy to treat atrial fibrillation: a first-in-human trial.
        Circ Arrhythm Electrophysiol. 2020; 13: e008718
        • Reddy V.Y.
        • Dukkipati S.R.
        • Neuzil P.
        • et al.
        Pulsed field ablation of paroxysmal atrial fibrillation: 1-year outcomes of IMPULSE, PEFCAT, and PEFCAT II.
        JACC Clin Electrophysiol. 2021; 7: 614-627
        • Yavin H.D.
        • Higuchi K.
        • Sroubek J.
        • et al.
        Pulsed-field ablation in ventricular myocardium using a focal catheter: the impact of application repetition on lesion dimensions.
        Circ Arrhythm Electrophysiol. 2021; 14: e010375
        • Gerard I.J.
        • Bernier M.
        • Hijal T.
        • et al.
        Stereotactic Arrhythmia Radioablation for Ventricular Tachycardia: Single Center First Experiences.
        Advances in Radiation Oncology. 2021; 6https://doi.org/10.1016/j.adro.2021.100702